Board of Directors
Frank Verwiel MD
Dr. Verwiel joined Achillion’s Board of Directors in December 2016. Prior to its acquisition in 2014 by Forest Laboratories, Dr. Verwiel served as President, Chief Executive Officer and Board member at Aptalis Pharma. Prior to Aptalis, he held international senior management positions with Merck & Co. Inc. and at Servier.